The Coagulation Abnormalities in Systemic Lupus Erythematosus

Summary

An anticoagulant occurring in 4 of 6 patients with SLE has been demonstrated by a sensitive assay utilizing an ammonium sulfate fraction of serum. The anticoagulant functions as an inhibitor of the activation of prothrombin. No species specificity was demonstrable. The inhibitor behaves clinically and chromatographically as an immunoglobulin, although an attempt to demonstrate directly the antibody nature of the inhibitor was not successful.

A severe, apparently independent, decrease in the level of prothrombin was observed in the patient with hemorrhagic symptoms. In contrast to the anticoagulant activity, the low prothrombin has persisted during treatment.

• References

• 1 Conley C.L, Hartmann R.C. A Hemorrhagic Disorder Caused by Circulating Anticoagulant in Patients with Disseminated Lupus Erythematosus. J. clin. Invest 1952; 31: 621
• 2 Frick P.G. Acquired Circulating Anticoagulants in Systemic “Collagen Disease”. Blood 1955; 10: 691
• 3 Ramot B, Singer K. An Unusual Circulating Anticoagulant in Systemic Lupus Erythematosus. Actahaemat. (Basel) 1956; 16: 158
• 4 Bonnin J.A, Cohen A.K, Hicks N.D. Coagulation Defects in a Case of Systemic Lupus Erythematosus with Thrombocytopenia. Brit. J. Haemat 1956; 2: 168
• 5 Rapaport S.I, Ames S.B, Duvall B.J. A Plasma Coagulation Defect in Systemic Lupus Erythematosus Arising from Hypoprothrombinemia Combined with Antiprothrombinase Activity. Blood 1960; 15: 212
• 6 Margolius A, Jackson D.P, Ratnoff O.D. Circulating Anticoagulants: A Study of 40 Cases and a Review of the Literature. Medicine 1961; 40: 145
• 7 Breckenridge R.T, Ratnoff O.D. Studies on the Site of Action of a Circulating Anticoagulant in Disseminated Lupus Erythematosus. Amer. J. Med 1963; 35: 813
• 8 Hougie C. Naturally Occurring Species Specific Inhibitor of Human Prothrombin in Lupus Erythematosus. Proc. Soc. exp. Biol. (N. Y.) 1964; 116: 359
• 9 Biggs R, Benson K.W.E. The Mode of Action of a Coagulation Inhibitor in the Blood of Two Patients with Disseminated Lupus Erythematosus. Brit. J. Haemat 1964; 10: 198
• 10 Yin E.T, Gaston L.W. Purification and Kinetic Studies on a Circulating Anticoagulant in a Suspected Case of Lupus Erythematosus. Thrombos. Diathes. haemorrh. (Stuttg.) 1965; 14: 88
• 11 Lee S.L, Sanders M. A Disorder of Blood Coagulation in Systemic Lupus Erythematosus. J. clin. Invest 1955; 34: 1814
• 12 Loeliger A. Prothrombin as a Co-Factor of the Circulating Anticoagulant in Systemic Lupus Erythematosus. Thrombos. Diathes. haemorrh. (Stuttg.) 1959; 3: 237
• 13 Ware A.G, Seegers W.H. Two-stage Procedure for the Quantitative Determination of Prothrombin Concentration. Amer. J. clin. Path 1949; 19: 471
• 14 Gonyea L.M, Bridges R.A. Electrophoretic Behavior of Bovine Prothrombin. Scand. J. clin. Lab. Invest 1965; 17 (Suppl. 84) 33
• 15 Quick A.J, Stanley-Brown M, Bancroft F.W. A Study of the Coagulation Defect in Hemophilia and in Jaundice. Amer. J. med. Sci 1935; 190: 501
• 16 Langdell R.D, Wagner R.H, Brinkhous K.M. Effect of Antihemophilic Factor on One-stage Clotting Tests. J. Lab. clin. Med 1953; 41: 637
• 17 Rasmussen P.S. Purification of Thrombin by Chromatography. Biochim. biophys. Acta (Amst.) 1955; 16: 157
• 18 Stormorken H. Species Differences of Clotting Factors in Ox, Dog. Horse and Man. Acta physiol. scand 1957; 39: 301 121; 40 167 41 101; 41
• 19 Gonyea L.M. Unpublished observations.
• 20 Friou G.J. In: Cohen A.S. Laboratory Diagnostic Procedures in the Rheumatic Diseases. (Chapt. 5.). Little Brown and Co.; Boston: 1967